BSX Shariah Compliance

Screening Methodology: AAOIFI

lock image
LOCKED

Analyst's Ratings

Based on 38 analysts giving stock ratings to Boston Scientific Corp in the past 3 months

Strong
Sell
SellHoldBuyStrong
Buy
Strong Buy
32
Buy
55
Hold
13
Sell
0
Strong Sell
0
Boston Scientific Corp

Boston Scientific Corp. Stock Analysis BSX

United States Health Care Large Cap
Boston Scientific Corp. engages in the development, manufacture, and marketing of medical devices that are used in interventional medical procedures. The company is headquartered in Marlborough, Massachusetts and currently employs 53,000 full-time employees. Its MedSurg segment includes Endoscopy, Urology and Neuromodulation. Its Endoscopy business develops and manufactures devices to diagnose and treat a broad range of gastrointestinal (GI) and pulmonary conditions with less invasive technologies. Its Urology business develops and manufactures devices to treat various urological conditions for both male and female anatomies. Its Neuromodulation business develops and manufactures devices to treat various neurological movement disorders and manage chronic pain. Its Cardiovascular segment includes Cardiology and Peripheral Interventions. Its Interventional Cardiology Therapies business develops and manufactures technologies for diagnosing and treating coronary artery disease and aortic valve conditions. The company also owns the transcarotid artery revascularization (TCAR) platform.
Read More

BSX Chart

United States Health Care Large Cap

Boston Scientific Corp vs S&P 500 Comparative Returns

Analysis of BSX stock performance compared to the broader market (S&P 500) across multiple timeframes.

YTD Performance
  • Boston Scientif... (BSX...) 15.64%
  • S&P 500 -4.27%
Boston Scientif... Outperformed S&P 500 by 19.91%
1Y Performance
  • Boston Scientif... (BSX...) 42.04%
  • S&P 500 8.86%
Boston Scientif... Outperformed S&P 500 by 33.18%
3Y Performance
  • Boston Scientif... (BSX...) 169.76%
  • S&P 500 37.21%
Boston Scientif... Outperformed S&P 500 by 132.55%
5Y Performance
  • Boston Scientif... (BSX...) 170.53%
  • S&P 500 92.3%
Boston Scientif... Outperformed S&P 500 by 78.23%

Key Statistics

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

$102.53$103.66

Today's Open

$102.97

Volume

5.28M

P/E Ratio (TTM)

74.89

52 Week Range

$66.80$107.17

Market Cap

151.86B

Avg. Volume

8.02M

Dividend Yield

-

Financial Metrics & Statements

  • Per Share Data
  • Ratios
  • Statements
Currency: USD20202021202220232024
Revenue per Share (TTM)
7 8.34 8.85 9.72 -
EBIT per Share (TTM)
0.64 1.48 1.45 1.66 -
Earnings per Share (EPS) (TTM)
-0.08 0.69 0 1 -
Dividend per Share (TTM)
0.02 0.04 0.04 0.02 -
EPS Forward
-0.06 0.73 0.48 1.09 1.25

Super Investors

View All

Super Investors are top-performing investors known for their exceptional market strategies and long-term success in wealth creation.

lock-image

FAQ's

Halal stocks refer to shares of companies that comply with Islamic finance principles, meaning they do not engage in businesses related to alcohol, gambling, pork, or interest-based financial services.